inDividual, Targeted thrombosIS Prophylaxis Versus the Standard 'One Size Fits All' Approach in Patients Undergoing Total hIp or Total kNee replaCemenT

Recruiting

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(10 sites)

Netherlands

Gelre Ziekenhuizen, Apeldoorn, Gelderland

Zuyderland, Geleen, Limburg

Anna Ziekenhuis, Geldrop, North Brabant

Bravis ziekenhuis, Roosendaal, North Brabant

Elisabeth-TweeSteden Ziekenhuis, Tilburg, North Brabant

OLVG, Amsterdam, North Holland

Bergman Clinics, Naarden, North Holland

Isala ziekenhuis, Zwolle, Overijssel

Alrijne, Leiderdorp, South Holland

Reinier Haga Orthopedisch Centrum, Zoetermeer, South Holland